Editas Medicine EDIT
NASDAQ EDIT
$3.23 +0.15 (+4.87%)
At close: Sep 4, 2026 · 4:00 PM EDT

Editas Medicine (EDIT) Amortizatization of Intangibles (2023 - 2024)

Editas Medicine (EDIT) posted quarterly Amortizatization of Intangibles of $1.3 million for Q3 2024, up 6.34% year-over-year from $1.2 million in Q4 2023, and down 29.47% quarter-over-quarter from $1.9 million in Q2 2024.

Analysis

Editas Medicine (EDIT) Amortizatization of Intangibles (2023 - 2024) Analysis & Trends

Editas Medicine (EDIT) has reported Amortizatization of Intangibles for 2 consecutive years, with $1.3 million the latest figure, recorded in Q3 2024.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.33 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 678,000.00
10 Editas Medicine 287.84 Mn 141.19 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 1.33 Mn
Jun 30, 2024 1.88 Mn
Mar 31, 2024 1.72 Mn
Sep 30, 2023 1.25 Mn
Jun 30, 2023 780,000.00
Mar 31, 2023 693,000.00